Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Suzuki, Takefumi
Remington, Gary
Mulsant, Benoit H.
Rajji, Tarek K.
Uchida, Hiroyuki
Graff-Guerrero, Ariel
and
Mamo, David C.
2011.
Treatment resistant schizophrenia and response to antipsychotics: A review.
Schizophrenia Research,
Vol. 133,
Issue. 1-3,
p.
54.
Suzuki, Takefumi
Remington, Gary
Uchida, Hiroyuki
Rajji, Tarek K.
Graff-Guerrero, Ariel
and
Mamo, David C.
2011.
Management of Schizophrenia in Late Life with Antipsychotic Medications.
Drugs & Aging,
Vol. 28,
Issue. 12,
p.
961.
Suzuki, Takefumi
Remington, Gary
Mulsant, Benoit H.
Uchida, Hiroyuki
Rajji, Tarek K.
Graff-Guerrero, Ariel
Mimura, Masaru
and
Mamo, David C.
2012.
Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation.
Psychiatry Research,
Vol. 197,
Issue. 1-2,
p.
1.
Suzuki, Takefumi
Uchida, Hiroyuki
Watanabe, Koichiro
and
Mimura, Masaru
2013.
Polypharmacy in Psychiatry Practice, Volume II.
p.
81.
Anghelescu, Ion-George
Janssens, Luc
Kent, Justine
de Boer, Peter
Tritsmans, Luc
Daly, Ella J.
van Nueten, Luc
and
Schmidt, Mark E.
2013.
Does early improvement predict response to the fast-dissociating D2 receptor antagonist JNJ-37822681 in patients with acute schizophrenia? ☆.
European Neuropsychopharmacology,
Vol. 23,
Issue. 9,
p.
1043.
Kim, Jong-Hoon
Yi, Sang Hoon
Lee, Jinyoung
and
Kim, Yong Sik
2013.
Effects of Clozapine on Heart Rate Dynamics and Their Relationship With Therapeutic Response in Treatment-Resistant Schizophrenia.
Journal of Clinical Psychopharmacology,
Vol. 33,
Issue. 1,
p.
69.
Dold, Markus
and
Leucht, Stefan
2014.
Pharmakotherapie der therapieresistenten Schizophrenie.
PSYCH up2date,
Vol. 8,
Issue. 05,
p.
281.
2014.
Therapie Psychischer Erkrankungen.
p.
1.
Woodward, Todd S.
Jung, Kwanghee
Smith, Geoffrey N.
Hwang, Heungsun
Barr, Alasdair M.
Procyshyn, Ric M.
Flynn, Sean W.
van der Gaag, Mark
and
Honer, William G.
2014.
Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 264,
Issue. 8,
p.
673.
Dold, Markus
and
Leucht, Stefan
2014.
Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective.
Evidence Based Mental Health,
Vol. 17,
Issue. 2,
p.
33.
Tracy, Derek K.
and
Shergill, Sukhwinder S.
2014.
Treatment–Refractory Schizophrenia.
p.
1.
Chiliza, Bonginkosi
Asmal, Laila
Kilian, Sanja
Phahladira, Lebogang
and
Emsley, Robin
2015.
Rate and predictors of non‐response to first‐line antipsychotic treatment in first‐episode schizophrenia.
Human Psychopharmacology: Clinical and Experimental,
Vol. 30,
Issue. 3,
p.
173.
2015.
Therapie Psychischer Erkrankungen.
p.
e1.
Hargarter, Ludger
Cherubin, Pierre
Bergmans, Paul
Keim, Sofia
Rancans, Elmars
Bez, Yasin
Parellada, Eduard
Carpiniello, Bernardo
Vidailhet, Pierre
and
Schreiner, Andreas
2015.
Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 58,
Issue. ,
p.
1.
Bülow, Per
Andersson, Gunnel
Denhov, Anne
and
Topor, Alain
2016.
Experience of Psychotropic Medication –An Interview Study of Persons with Psychosis.
Issues in Mental Health Nursing,
Vol. 37,
Issue. 11,
p.
820.
Kishi, Taro
2016.
Lack of improvement at week 2 predicts later antipsychotic non-response in people with acute exacerbations of schizophrenia or schizophrenia-like psychosis.
Evidence Based Mental Health,
Vol. 19,
Issue. 2,
p.
61.
Noordraven, Ernst L
Wierdsma, André I
Blanken, Peter
Bloemendaal, Anthony F T
Staring, Anton B P
and
Mulder, Cornelis L
2017.
Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
The Lancet Psychiatry,
Vol. 4,
Issue. 3,
p.
199.
Yoshimura, Bunta
Yada, Yuji
So, Ryuhei
Takaki, Manabu
and
Yamada, Norihito
2017.
The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.
Psychiatry Research,
Vol. 250,
Issue. ,
p.
65.
Takeuchi, Hiroyoshi
Kantor, Navot
Sanches, Marcos
Fervaha, Gagan
Agid, Ofer
and
Remington, Gary
2017.
One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis.
British Journal of Psychiatry,
Vol. 211,
Issue. 3,
p.
137.
2017.
Therapie psychischer Erkrankungen.
p.
1.